Please assess the completion status of the following clinical trial:

Trial Title: The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* All subjects who received inactivated or attenuated alive HAV vaccine in the previous trial~Exclusion Criteria:~* Subjects who refused to continue in the follow-up study

- Gender: ALL
- Minimum Age: 18 Months
- Maximum Age: 35 Months
- Healthy Volunteers: t

Study Arms:
- Inactivated HAV vaccine (Type: None): Inactivated vaccine: 0.5 ml per dose containing 250 u antigen, one dose
- Attenuated alive HAV vaccine (Type: None): Attenuated alive vaccine: 1.0 ml per dose containing 6.50 lgCCID50 alive virus, one dose

Based on this trial design, predict the completion outcome and termination type (if applicable).